全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Transient Hiccups Associated with Oral Dexamethasone

DOI: 10.1155/2013/426178

Full-Text   Cite this paper   Add to My Lib

Abstract:

Hiccups, or singulata (hiccup is singultus), are commonly experienced by most people at one time or another and are usually brief and self-limiting. Although pharmacotherapeutic agents are not generally considered causal in the etiology of hiccups, many clinicians empirically associate episodic hiccups in their patients as being drug induced. The two classes of drugs most often cited as causing hiccups are corticosteroids and benzodiazepines. This report involved a patient who was given preoperative dexamethasone and developed hiccups before anesthesia and surgery commenced. He at no time was in distress, and the surgical procedure was completed without complication. By the second postsurgical day his hiccups were resolved completely. Although the association may be anecdotal, many clinicians consider hiccups a potential side effect of steroid therapy, especially high doses of steroids. Of interest in this case is the relatively low dose of corticosteroid used, albeit apparently linked to his hiccups. Practitioners should be aware of this potential condition. 1. Introduction Hiccups, or singulata (hiccup is singultus), are very common and are experienced by most people at one time or another. They are usually brief and self-limiting but may become prolonged in some patients [1]. Hiccups that linger on for some time may become worrisome to the postoperative patient, thus hindering their nutritional and sleep needs [2, 3]. Hiccups are sudden, uncontrolled contractions of the diaphragm, followed by immediate inspiration and closure of the glottis over the trachea, producing the “hiccup” sound [4]. The classification of hiccups is as follows: up to 48 hours, acute or transient; longer than 48 hours, persistent; and more than a month or two, intractable [5]. The frequency of hiccups in males and females is equivalent, although intractable hiccups occur at a much higher rate in men [6, 7]. The exact etiology of the hiccup is unknown, but the neural process involves the reflex arc consisting of the afferent limb, the center, and the efferent limb [8, 9]. The afferent limb contains the phrenic and vagus nerves together with the sympathetic chain from T6 to T12. The center is linked to the afferent and efferent limbs and occupies a nonspecific location somewhere between C3 and C5. The efferent limb includes the phrenic nerve, accessory respiratory muscles, the glottis, and autonomic processes involving the medullary reticular formation and hypothalamus [4, 10]. One review proposed that the hiccup reflex arc is a myoclonic action and not a true reflex [11].

References

[1]  Y.-M. Hung, M. A. Miller, and M. M. Patel, “Persistent hiccups associated with intravenous corticosteroid therapy,” Journal of Clinical Rheumatology, vol. 9, no. 5, pp. 306–309, 2003.
[2]  I. Arnulf, D. Boisteanu, W. A. Whitelaw, J. Cabane, L. Garma, and J.-P. Derenne, “Chronic hiccups and sleep,” Sleep, vol. 19, no. 3, pp. 227–231, 1996.
[3]  D. Garvey, “Post-operative hiccups,” Proceedings of UCLA HealthCare, vol. 4, pp. 19–21, 2000.
[4]  P. W. Kolodzik and M. A. Eilers, “Hiccups (singultus): review and approach to management,” Annals of Emergency Medicine, vol. 20, no. 5, pp. 565–573, 1991.
[5]  H. S. Smith and A. Busracamwongs, “Management of hiccups in the palliative care population,” American Journal of Hospice and Palliative Medicine, vol. 20, no. 2, pp. 149–154, 2003.
[6]  J. Ross, M. Eledrisi, and P. Casner, “Persistent hiccups induced by dexamethasone,” Western Journal of Medicine, vol. 170, no. 1, pp. 51–52, 1999.
[7]  J. V. Souadjian and J. C. Cain, “Intractable hiccup. Etiologic factors in 220 cases,” Postgraduate Medicine, vol. 43, no. 2, pp. 72–77, 1968.
[8]  J. H. Lewis, “Hiccups: causes and cures,” Journal of Clinical Gastroenterology, vol. 7, no. 6, pp. 539–552, 1985.
[9]  S. Launois, J. L. Bizec, W. A. Whitelaw, J. Cabane, and J. Derenne, “Hiccup in adults: an overview,” European Respiratory Journal, vol. 6, no. 4, pp. 563–575, 1993.
[10]  J. J. M. Askenasy, “About the mechanism of hiccup,” European Neurology, vol. 32, no. 3, pp. 159–163, 1992.
[11]  E. C. Lauterbach, “Hiccup and apparent myoclonus after hydrocodone: review of the opiate-related hiccup and myoclonus literature,” Clinical Neuropharmacology, vol. 22, no. 2, pp. 87–92, 1999.
[12]  C. M. Fisher, “Protracted hiccup—a male malady,” Transactions of the American Neurological Association, vol. 92, pp. 231–233, 1967.
[13]  Y. Takiguchi, R. Watanabe, K. Nagao, and T. Kuriyama, “Hiccups as an adverse reaction to cancer chemotherapy,” Journal of the National Cancer Institute, vol. 94, no. 10, pp. 772–774, 2002.
[14]  D. F. Thompson and J. P. Landry, “Drug-induced hiccups,” Annals of Pharmacotherapy, vol. 31, no. 3, pp. 367–369, 1997.
[15]  C.-C. Liaw, C.-H. Wang, H.-K. Chang et al., “Cisplatin-related hiccups: male predominance, induction by dexamethasone, and protection against nausea and vomiting,” Journal of Pain and Symptom Management, vol. 30, no. 4, pp. 359–366, 2005.
[16]  R. D. Dickerman and S. Jaikumar, “The hiccup reflex arc and persistent hiccups with high-dose anabolic steroids: is the brainstem the steroid-responsive locus?” Clinical Neuropharmacology, vol. 24, no. 1, pp. 62–64, 2001.
[17]  R. D. Dickerman, C. Overby, M. Eisenberg, P. Hollis, and M. Levine, “The steroid-responsive hiccup reflex arc: competitive binding to the corticosteroid-receptor?” Neuroendocrinology Letters, vol. 24, no. 3-4, pp. 167–169, 2003.
[18]  R. J. Cersosimo and M. T. Brophy, “Hiccups with high dose dexamethasone administration: a case report,” Cancer, vol. 82, pp. 412–414, 1998.
[19]  F. Jover, J. M. Cuadrado, and J. Merino, “Possible azithromycin-associated hiccups,” Journal of Clinical Pharmacy and Therapeutics, vol. 30, no. 4, pp. 413–416, 2005.
[20]  J. Micallef, S. Tardieu, V. Pradel, and O. Blin, “Benzodiazepine and hiccup: three case reports,” Therapie, vol. 60, no. 1, pp. 57–60, 2005.
[21]  P. Marhofer, C. Glaser, C. G. Krenn, C. M. Grabner, and M. Semsroth, “Incidence and therapy of midazolam induced hiccups in paediatric anaesthesia,” Paediatric Anaesthesia, vol. 9, no. 4, pp. 295–298, 1999.
[22]  H. Miyaoka and K. Kamijima, “Perphenazine-induced hiccups,” Pharmacopsychiatry, vol. 32, no. 2, p. 81, 1999.
[23]  P. A. LeWitt, N. W. Barton, and J. B. Posner, “Hiccup with dexamethasone therapy,” Annals of Neurology, vol. 12, no. 4, pp. 405–406, 1982.
[24]  J. J. Vazquez, “Persistent hiccup as a side-effect of dexamethasone treatment,” Human and Experimental Toxicology, vol. 12, no. 1, p. 52, 1993.
[25]  B. A. Baethge and M. D. Lidsky, “Intractable hiccups associated with high-dose intravenous methylprednisolone therapy,” Annals of Internal Medicine, vol. 104, no. 1, pp. 58–59, 1986.
[26]  S. MacKay and S. Eisendrath, “Adverse reaction to dental corticosteroids,” General Dentistry, vol. 40, no. 2, pp. 136–138, 1992.
[27]  S. Mehta, D. L. Nelson, J. R. Klinger, G. B. Buczko, and M. M. Levy, “Prediction of post-extubation work of breathing,” Critical Care Medicine, vol. 28, no. 5, pp. 1341–1346, 2000.
[28]  D. C. Lipps, B. Jabbari, M. H. Mitchell, and J. D. Daigh Jr., “Nifedipine for intractable hiccups,” Neurology, vol. 40, no. 3, pp. 531–532, 1990.
[29]  N. L. Friedman, “Hiccups: a treatment review,” Pharmacotherapy, vol. 16, no. 6, pp. 986–995, 1996.
[30]  N. Szigeti and G. Fábián, “Prolonged hiccups—successful medical therapy,” Orvosi Hetilap, vol. 146, no. 41, pp. 2117–2119, 2005.
[31]  R. Moretti, P. Torre, R. M. Antonello, M. Ukmar, G. Cazzato, and A. Bava, “Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up,” Neurologist, vol. 10, no. 2, pp. 102–106, 2004.
[32]  G. Petroianu, G. Hein, A. Stegmeier-Petroianu, W. Bergler, and R. R. Gabapentin, ““Add-on therapy” for idiopathic chronic hiccup (ICH),” Journal of Clinical Gastroenterology, vol. 30, pp. 321–324, 2000.
[33]  Y.-C. Lin, “Acupuncture for persistent hiccups in a heart and lung transplant recipient,” Journal of Heart and Lung Transplantation, vol. 25, no. 1, pp. 126–127, 2006.
[34]  P. Walker, S. Watanabe, and E. Bruera, “Baclofen, a treatment for chronic hiccup,” Journal of Pain and Symptom Management, vol. 16, no. 2, pp. 125–132, 1998.
[35]  P. Gilbar and I. McPherson, “Severe hiccups during chemotherapy: corticosteroids the likely culprit,” Journal of Oncology Pharmacy Practice, vol. 15, no. 4, pp. 233–236, 2009.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133